This chapter serves as an epilogue, synthesizing the neurobiological understanding of maladaptation presented throughout the book to explore novel therapeutic strategies rooted in neuroscience. It begins by discussing neurofeedback, a technique where individuals learn to consciously regulate their own brain activity, which has been shown to be useful for managing conditions like chronic pain and anxiety. The discussion then shifts to more direct methods of intervention, including various forms of brain stimulation and inhibition, such as deep brain stimulation, transcranial magnetic stimulation (TMS), and transcranial focused ultrasound (tFUS). Additionally, the chapter explores the emerging potential of stem cell treatments for repairing neurological damage related to maladaptive disorders. Finally, it addresses the future of precision medicine through pharmacogenomics, illustrating how genetic information is being used to tailor pharmaceutical interventions for greater efficacy and fewer side effects in treating these complex conditions.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Using Neuroscience to Treat Maladaptation

  • Justin R. Yates

摘要

This chapter serves as an epilogue, synthesizing the neurobiological understanding of maladaptation presented throughout the book to explore novel therapeutic strategies rooted in neuroscience. It begins by discussing neurofeedback, a technique where individuals learn to consciously regulate their own brain activity, which has been shown to be useful for managing conditions like chronic pain and anxiety. The discussion then shifts to more direct methods of intervention, including various forms of brain stimulation and inhibition, such as deep brain stimulation, transcranial magnetic stimulation (TMS), and transcranial focused ultrasound (tFUS). Additionally, the chapter explores the emerging potential of stem cell treatments for repairing neurological damage related to maladaptive disorders. Finally, it addresses the future of precision medicine through pharmacogenomics, illustrating how genetic information is being used to tailor pharmaceutical interventions for greater efficacy and fewer side effects in treating these complex conditions.